Internet survey on the prevalence of constipation in patients with schizophrenia and depression - CONSIDER survey

Internet survey on the prevalence of constipation in patients with schizophrenia and depression - CONSIDER survey - Internet survey on the prevalence of constipation in patients with schizophrenia and depression - CONSIDER survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058981

Enrollment

800

Registered

2025-09-12

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia, depression

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: People with schizophrenia or depression, as well as members of the general public, who are registered with Cross Marketing Inc.'s research cooperation panel and have agreed to participate in this survey.

Exclusion criteria

Exclusion criteria: Nothing in particular

Design outcomes

Primary

Measure	Time frame
Exploratory examination of the following indicators Quality of Life (SF-8) Work Productivity (WPAI) Constipation Scoring System (CSS) Stool consistency (Bristol Stool Form Scale) Constipation status (type of constipation, presence or absence of urge to defecate, presence or absence of abdominal distension, etc.) Treatment status and satisfaction with constipation, preferences for medication administration methods, expectations and concerns regarding medications Stratified analysis of patient background and factors associated with constipation	—

Measure

Time frame

Exploratory examination of the following indicators Quality of Life (SF-8) Work Productivity (WPAI) Constipation Scoring System (CSS) Stool consistency (Bristol Stool Form Scale) Constipation status (type of constipation, presence or absence of urge to defecate, presence or absence of abdominal distension, etc.) Treatment status and satisfaction with constipation, preferences for medication administration methods, expectations and concerns regarding medications Stratified analysis of patient background and factors associated with constipation

—

Countries

Japan

Contacts

Public ContactShinji Yoneda

EA Pharma Co., Ltd. Medical Science Group, Medical Dept.

shinji_yoneda@eapharma.co.jp080-5900-4282

Outcome results